These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15706675)

  • 1. [Cerebral infarct and atypical antipsychotic agents].
    Lacomblez L
    Psychol Neuropsychiatr Vieil; 2004 Dec; 2(4):299. PubMed ID: 15706675
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychosis of Alzheimer disease.
    Snowdon J
    Am J Geriatr Psychiatry; 2006 Mar; 14(3):293-4. PubMed ID: 16505135
    [No Abstract]   [Full Text] [Related]  

  • 3. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of atypical antipsychotics in patients with Alzheimer's dementia. CATIE-AD-Study (Clinical Antipsychotic Trials of Intervention Effectiveness Alzheimer's Disease)].
    Förstl H
    Internist (Berl); 2007 Jun; 48(6):642-4. PubMed ID: 17497111
    [No Abstract]   [Full Text] [Related]  

  • 5. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic treatment of psychosis and agitation in the elderly.
    Daniel DG
    J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of risk of cerebrovascular events in an elderly VA population with dementia between antipsychotic and nonantipsychotic users.
    Barnett MJ; Wehring H; Perry PJ
    J Clin Psychopharmacol; 2007 Dec; 27(6):595-601. PubMed ID: 18004126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Authors' response to comments regarding risperidone versus olanzapine Markov model.
    Value Health; 2005; 8(5):613-4. PubMed ID: 16176499
    [No Abstract]   [Full Text] [Related]  

  • 10. Underlying mechanisms of psychosis and aggression in patients with Alzheimer's disease.
    Mintzer JE
    J Clin Psychiatry; 2001; 62 Suppl 21():23-5. PubMed ID: 11584984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agitation and psychosis in dementia.
    Ballard C
    Am J Geriatr Psychiatry; 2007 Nov; 15(11):913-7. PubMed ID: 17974863
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effectiveness of rispolept in mental disorders in patients with Alzheimer and vascular types of dementia].
    Shamreĭ VK; Kolchev AI; Dobrovol'skaia NV
    Voen Med Zh; 2002 Nov; 323(11):47-51. PubMed ID: 12532483
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimizing atypical antipsychotic treatment strategies in the elderly.
    Katz IR
    J Am Geriatr Soc; 2004 Dec; 52(12 Suppl):S272-7. PubMed ID: 15541168
    [No Abstract]   [Full Text] [Related]  

  • 14. [Atypical neuroleptics in dementia. Managing behavioral disorders early and efficiently].
    MMW Fortschr Med; 2002 Mar; 144(10):60-1. PubMed ID: 11928271
    [No Abstract]   [Full Text] [Related]  

  • 15. The outpatient use of atypical antipsychotics with Alzheimer's disease.
    Farver D
    S D Med; 2007 Mar; 60(3):113, 115. PubMed ID: 17455580
    [No Abstract]   [Full Text] [Related]  

  • 16. The management of psychogeriatric patient.
    Zannino G; Gargiulo A; Lamenza F; Marotta MG; Barzotti T; Silvestri A; Ettorre E; Marigliano V
    Arch Gerontol Geriatr Suppl; 2004; (9):465-70. PubMed ID: 15207448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antipsychotic treatment of dementia after publication of new risks].
    Wittmann M; Hausner H; Hajak G; Haen E;
    Psychiatr Prax; 2010 Mar; 37(2):68-70. PubMed ID: 19724997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of atypical antipsychotics in dementia: rethinking Simpson's paradox.
    Suh GH
    Int Psychogeriatr; 2009 Aug; 21(4):616-21. PubMed ID: 19243653
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of early dysphoric response and cannabis use on discontinuation of olanzapine or risperidone in patients with early psychosis.
    van Nimwegen-Campailla L; van Beveren N; Laan W; van den Brink W; Linszen D; de Haan L
    Pharmacopsychiatry; 2010 Nov; 43(7):281. PubMed ID: 20839158
    [No Abstract]   [Full Text] [Related]  

  • 20. Discontinuation of risperidone, olanzapine, and haloperidol in first-episode psychosis.
    Shim JC; Choe BM; Kim JG; Jae YM; Kim HC; Kim SG; Oh MK; Kelly DL; Conley RR
    J Clin Psychopharmacol; 2007 Aug; 27(4):400-1. PubMed ID: 17632229
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.